Cogent Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2017
Total Assets: $49.1M
Liabilities Breakdown FY2017
Total Liabilities: $20.8M
Asset Breakdown
Total Assets: $49.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $28.3M | 57.6% |
| Accounts Receivable | $830.0K | 1.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.1M | 8.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $15.9M | 32.4% |
Liabilities Breakdown
Total Liabilities: $20.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.3M | 6.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $19.5M | 93.5% |